Bone Marrow Aspirate Concentrates (BMAC ) Market Trends
Market expansion is anticipated to be propelled by the rising prevalence of orthopaedic disorders. BMAC offers a regenerative treatment option for these conditions, providing patients and healthcare providers with an alternative to traditional therapies.
For instance, according to The World Health Organization (WHO), in 2023, approximately 1.71 billion people worldwide had musculoskeletal conditions.
Similarly, according to the Centers for Disease Control and Prevention (CDC), among adults aged 45 to 64 years, one in four (26%) reported being diagnosed with arthritis, while among adults aged 65 years or older, almost half (47.3%) reported arthritis.
Furthermore, with an active lifestyle and increased participation in sports, the incidence of fractures and trauma has risen. BMAC aids in bone healing and regeneration, accelerating the recovery process for patients with fractures."
Conditions like degenerative disc disease, tendinitis, and bursitis are becoming more prevalent. Bone marrow aspirate concentrate has shown efficacy in treating these degenerative conditions by promoting tissue repair and reducing inflammation.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Why is the demand for bone marrow aspirate concentrates market?
BMAC market from the bone marrow aspirate concentrates systems product segment reached USD 108.2 million in 2023, driven by their rising need for efficiently processing bone marrow aspirate, separating it into its various components.
Bone marrow aspirate concentrates market size from the orthopaedic surgery segment is expected to record USD 81.3 million by 2032, led by the growing burden of osteoarthritis, fractures, and sports injuries
North America bone marrow aspirate concentrates industry size was USD 70 million in 2023 and is predicted to witness substantial growth through 2032, due to the rising prevalence of orthopedic disorders, such as osteoarthritis and fractures